Heterologous expression of an active rat regulatory protein of glucokinase  by Detheux, Michel & Van Schaftingen, Emile
FEBS Letters 355 (1994) 27-29 
FEBS 14773 
Heterologous expression of an active rat regulatory protein of glucokinase 
Michel Detheux, Emile Van Schaftingen* 
Laboratoire de Chimie PhysiologQue, Universitk Catholique de Louvain and International Institute of Cellular and Molecular Pathology, 
Avenue Hippocrate 75, B-1200 Brussels, Belgium 
Received 13 October 1994 
Abstract The cDNA presumed to encode the rat liver regulatory protein of glucokinase has been expressed in Escherichia coli and a partially soluble 
protein has been obtained. This recombinant protein was partially purified and found to have the same apparent molecular mass as the regulatory 
protein purified from rat liver. Like the latter, it inhibited rat liver glucokinase competitively with respect o glucose and its effect was sensitive to 
fructose 6-phosphate and fructose l-phosphate. 
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1. Introdnction 
The liver of several species contains a regulatory protein that 
inhibits glucokinase competitively with respect o glucose [l-2]. 
In mammals, the effect of this regulatory protein is reinforced 
by fructose 6-phosphate and antagonized by fructose l-phos- 
phate. Based on partial amino acid sequences of the regulatory 
protein, cDNAs were recently isolated from rat liver libraries 
[3]. Expression of the corresponding coding sequence resulted 
in the production of a protein that was recognized by antibodies 
directed against the rat liver regulatory protein, but that was 
completely insoluble and inactive [3]. Since then, we have dis- 
covered that a sequencing error had led us to underestimate the 
length of the regulatory protein by about 60 residues [4]. In this 
paper we report the expression and the partial purification of 
a recombinant protein that has properties identical with those 
of the protein purified from rat liver. 
2. Materials and methods 
Restriction and modifying enzymes were from Boehringer, Gene- 
Amp DNA Amplification kit from Perkin Elmer Cetus and T7 sequent 
ing kit from Pharmacia. pUCgroE was kindly provided by J. Robbens, 
E. Remaut and W. Fiers (University of Ghent). 
2. I. Construction of the expression plasmid 
The protein was expressed in the expression system of Studier and 
Moffatt [5]. A full length cDNA devoid of mutation (termed PBS-PR) 
was constructed by ligation of a BspMVXhoI fragment of PBS-ZPRl 
to an EcoRUBspMI fragment of PBS-LPR17. The DNAcorresponding 
to the coding region of rat liver regulatory protein was PCR-amplified 
from PBS-PR, using one primer (5’.GCGAATTCATATGCCAGGC- 
ACCAAACG-3’) with a Ndel site containing the staticodon (under- 
lined), and the second primer (5’.ACGGATCCTCTAGAAATA- 
TCAATTCAGGJ’) containing the stop codon. The amplified DNA 
wasinserted in pBlueScript KS (+) T-vector [a], sequenced and then 
inserted in pET3a expression plasmid [5]. After cloning and amp&a- 
tion in XLl-Blue, the resulting plasmid termed PET-PR1900, was used 
to transform competent E. coli BL21(DE3) pLysS [5]. 
2.2. Expression, purification and assay of the recombinant protein 
The cells were grown and induced as described elsewhere [3]. The cells 
were then disrupted and the protein was purified as described in [7]. The 
regulatory protein was assayed by its ability to inhibit glucokinase [8]. 
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One unit of rat regulatory protein is defined as the amount causing 
half-maximal inhibition of 15 mU of glucokinase in 1 ml in the presence 
of 5 mM glucose and 100 PM sorbitol6-phosphate or 200 PM fructose 
6-phosphate [I]. Western blots were performed as in [9], using a rabbit 
antibody directed against rat liver regulatory protein, and revealed as 
in (101. 
3. Results and discussion 
The sequence corresponding to nucleotides 22-1905 of the 
rat liver cDNA [4] was inserted in an expression plasmid PET 
[5]. Addition of 0.4 mM isopropyl-p-D-thiogalactopyranoside 
to cells harboring this plasmid resulted in the appearance of a 
protein that had a mol&ular mass of ~65 kDa, identical with 
that of authentic rat liver regulatory protein, whereas no such 
protein was induced in control cells. Centrifugation of the ex- 
tracts at 30,000 x g for 10 min resulted in the sedimentation of 
all the recombinant protein when the bacteria had been grown 
and induced in tryptone-phosphate medium at 23°C or 37°C 
or in M9 medium at 37°C. Thus, the protein produced under 
these conditions was presumably present only in inclusion bod- 
ies. A small amount, estimated to about 5% of the recombinant 
protein, was however found to be soluble when the cells were 
grown in M9 medium at 23°C. A similar proportion was ob- 
tained when the plasmid was expressed in cells containing 
pUCgroE, a plasmid encoding the chaperonin GroEL [12]. 
The soluble form of regulatory protein was purified from 
cells grown and induced in M9 medium at 23°C. The fractions 
eluted from the anion-exchange column at 100 mM NaCl con- 
tained the ca 65 kDa recombinant protein and inhibited glucok- 
inase; no inhibition was found with fractions derived from 
control cells (not shown). From a 3 1 culture, ca. 600 units of 
regulatory protein could be purified with a specific activity of 
20 units per mg protein. A western blot performed with the 
partially purified protein showed that the recombinant protein 
reacted with antibodies directed against rat liver regulatory 
protein and that it had the same molecular mass as the latter 
(not shown). 
Like the native regulatory protein [l] the recombinant regu- 
latory protein inhibited rat liver glucokinase in a competitive 
manner with respect o glucose (Fig. 1). Its effect was greatly 
reinforced by fructose 6-phosphate (Fig. 2). Using the linearisa- 
tion method described in [ 1 I], we calculated a dissociation con- 
stant of 15 ,uM and 5 ,uM for the complexes formed by the 
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Fig. 1. Effect of the recombinant regulatory protein on the glucose 
saturation curve of rat liver glucokinase. The assays were carried out 
using the pyruvate kinase/lactate d hydrogenase coupled assay and 
contained 200 PM fructose 6-phosphate and, where indicated, 2U/ml 
of recombinant regulatory protein. 
regulatory protein and fructose 6-phosphate or sorbitol6-phos- 
phate respectively, in good agreement with the results obtained 
with the native regulatory protein (111. Fructose l-phosphate 
antagonized the inhibition exerted by the recombinant protein 
and its effect was competitive with fructose 6-phosphate (Fig. 
3), as previously observed for the protein purified from rat liver 
111. 
The recombinant protein that was produced in the present 
work has the same apparent molecular mass and the same 
kinetic effects on glucokinase as the protein purified from 
rat liver. These results provide therefore the final proof that the 
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Fig. 2. Effect of fructose 6-phosphate on the activity of glucokinase 
measured in the presence of different concentration of recombinant 
and, where indicated, of native (i.e. non-recombinant) rat liver regula- 
tory protein. Glucokinase was assayed at 5 mM glucose in the presence 
of the indicated concentrations of fructose 6-phosphate. 
Fig. 3. Effect of fructose l-phosphate on the activity of glucokinase 
measured in the presence of recombinant regulatory protein and dif- 
ferent concentrations of fructose 6-phosphate. All assays contained 
3.4 U/ml of recombinant regulatory protein. 
l-phosphate sensitive protein regulator of ghrcokinase. The 
protein that was previously expressed contained only 568 
amino acids of the regulatory protein plus 15 amino acids 
encoded by the vector. Its inactivity is best explained by the fact 
that it was completely insoluble. Such was also the case for a 
protein containing the first 512 amino acids of the regulatory 
protein (Detheux, unpublished results). These results suggest 
therefore that the carboxyterminal region of the regulatory 
protein is important for its solubility. 
The livers of at least two amphibians and one reptile contain 
a protein inhibitor of glucokinase that is insensitive to fructose 
6-phosphate and fructose l-phosphate [13]. The cDNA of the 
Xenopus liver has been recently cloned and found to be homol- 
ogous to the cDNA encoding rat liver regulatory protein [7]. 
At the protein level, the identity amounts to 57% and spreads 
over the whole sequence. The results of the present paper show 
that the sensitivity to fructose-phosphates i  not conferred to 
the rat regulatory protein by an extraneous factor but is an 
intrinsic property of the polypeptide whose cDNA was cloned. 
These results allow therefore the conclusion that two proteins 
with markedly different regulatory properties have evolved 
from one single ancestral gene. 
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